STOCK TITAN

Avadel Pharmaceu (AVDL) Net Income by Year

AVDL

Avadel Pharmaceu reported a net loss of $48.8M in fiscal year 2024. This represents an increase of 69.5% from the prior fiscal year. Over the trailing 12 months, Q4 FY2024 through Q3 FY2025, the same line adds up to a $278K net loss. The table below carries 15 fiscal years, from 2010 to 2024, and the quarters Avadel Pharmaceu has filed alongside them.

FY2024 annual
Net Income -$48.8M
YoY +69.5%
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2025, ended Sep 30, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

AVDL Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-KFY1010-K
Net Income-$278K-$48.8M+69.5%-$160.3M-16.6%-$137.5M-77.8%-$77.3M-1200.3%$7.0M+121.2%-$33.2M+65.1%-$95.3M-239.6%$68.3M+265.4%-$41.3M-198.8%$41.8M+148.9%-$85.5M-99.1%-$42.9M-1229.8%-$3.2M+63.2%-$8.8M+2.2%-$9.0M

TTM is the trailing twelve months, Q4 FY2024 through Q3 FY2025, summed from the four most recent quarterly filings.

AVDL Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-QQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-QQ2'2310-QQ1'2310-QQ4'2210-K
Net Income$20K+100.8%$9.7M+169.9%-$4.9M+82.0%-$5.0M-$2.6M+92.8%-$13.8M+78.5%-$27.3M+11.2%N/A-$36.3M-80.1%-$64.4M-1.6%-$30.8M-16.5%N/A

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Avadel Pharmaceu financials

Frequently Asked Questions

What was Avadel Pharmaceu's net income in fiscal year 2024?

Avadel Pharmaceu reported a net loss of $48.8M in fiscal year 2024.

How fast is Avadel Pharmaceu's net income growing?

Avadel Pharmaceu (AVDL) net income rose by 69.5% year over year, from -$160.3M to -$48.8M in fiscal year 2024.

What is Avadel Pharmaceu's net income over the last twelve months?

Avadel Pharmaceu (AVDL) reported a $278K net loss over the trailing 12 months, Q4 FY2024 through Q3 FY2025, summed from the four most recent quarterly filings.

Across the 15 fiscal years this page covers, Avadel Pharmaceu (AVDL) net income went from -$9.0M in fiscal year 2010 to -$48.8M in fiscal year 2024.

Avadel Pharmaceu (AVDL) reported $20K in net income in Q3 2025. This represents an increase of 100.8% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Avadel Pharmaceu (AVDL) reported on that line in every period on record.